Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Psychoneuroendocrinology. 2018 Jan 31;89:194–202. doi: 10.1016/j.psyneuen.2018.01.013

Table 2.

Here we dspict the distribution of genetic, and other subject information within groups of BD-I subjects based on presence or absence of comorbid AUD. AAO refers to age (in years) at onset of first episode. Functional Severity provides a rough estimate of the episode’s clinical impact with results ranging on a scale from 0 to 4 (0 – no symptoms, 1 - no impairment; 2 – impairment in secondary role; 3 – impairment in primary role; 4 – incapacitation). Number of Lifetime Episodes refers to patient report of the total number of respective mood episodes (i.e. mania or depression) in their lifetime.

Bipolar Disorder Type I Stats
with Co-Morbid AUD without Co-Morbid AUD
Mean Age (years +/− SD) 41.5 +/− 12.0 42.4 +/− 12.5 T = 0.37, p = 0.72
Sex F (n = 31) M (n = 13) F (n = 25) M (n = 19) Χ2 = 1.77, p = 0.18
Body Mass Index (+/− SD) 28.8 +/− 7.9 26.7 +/− 4.4 T = 0.86, p = 0.40
TSPO variant AA/AG (n = 22) GG (n = 22) AA/AG (n = 25) GG (n = 19) Χ2 = 0.41, p = 0.52
HAM-D 7.4 +/− 6.8 7.5 +/− 7.7 U = 0.29, p = 0.77
YMRS 2.6 +/− 3.9 2.1 +/− 2.4 U = −0.08, p = 0.94
Manic Episodes AAO (years) 20.5 +/− 12.4 25.6 +/− 11.8 U = −1.88, p = 0.06
Functional Severity 3.9 3.6 U = 1.03, p = 0.30
Number of Lifetime Episodes 15.8 10.8 U = 1.22, p = 0.22
Major Depressive Episodes AAO (years) 16.1 +/− 10.3 19.6 +/− 11.9 U = −1.48, p = 0.14
Functional Severity 3.1 3.3 U = −0.23, p = 0.82
Number of Lifetime Episodes 16.4 12.3 U = 0.14, p = 0.88